MORGAN KOHLER DRUG DISCOVERY ONLINE ARTICLES
-
![needs renovation-GettyImages-1327683208]( "Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers")
Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers10/6/2026Cyril Konto, MD, discusses Shennon Biotechnologies programs in small cell lung cancer, ovarian cancer, and hepatocellular carcinoma, and spans antibody and TCR-based T-cell engagers.
Morgan Kohler
Morgan Kohler is the executive editor for Drug Discovery Online, working with industry experts to develop insightful and informative pieces about drug discovery and preclinical drug development science, regulatory strategy, trends, analyses, and commentary. Morgan holds a master’s degree in professional writing and web content development and has worked in the publishing industry since 2018. Prior to working for Drug Discovery Online, she guided and edited industry expert-bylined content on topics related to radiology and economics.